AC Immune SA
https://www.acimmune.com/
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From AC Immune SA
Failure Of Roche’s Nine-Year Alzheimer’s Prevention Study Disappointing, But No Surprise
The ambitious prevention study in people with a nearly 100% chance of developing Alzheimer’s disease has failed, and attention will now switch to trial readouts for the next generation of beta-amyloid targeting candidates.
TauRx Attempts Anti-Tau Comeback But Keeps Data Under Wraps
The firm has revealed its anti-tau candidate showed promise in a late-stage Alzheimer’s study several years after a disappointing failure, but data are yet to be announced in full.
Blow For Sweden's BioArctic As AbbVie Exits Parkinson's Pact
Novartis and Roche may be committed to the target, but AbbVie has decided that its efforts in Parkinson's will not include a Phase II trial of its Swedish partner's alpha synuclein drug.
Minute Insight: First Live Images Of Alpha-Synuclein Raise Hope For Improved Neurological Diagnostics
Advancements in imaging technology may bring medtech and pharma closer together and lead to better drugs for neurological conditions.
Company Information
- Industry
- Pharmaceuticals
-
Pharmaceuticals
- Vaccines
-
Biotechnology
- Drug Discovery Tools
- Large Molecule
-
Large Molecule
- Antibodies
-
Drug Discovery Tools
- Molecular Diversity
- Other Names / Subsidiaries
-
- AC Immune, Ltd.